NCT07379216

Brief Summary

The objective of this study is to evaluate the effect of liquid vitamin C and glutathione supplements on human skin condition improvement and anti-oxidation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

January 23, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

January 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 30, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2026

Expected
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

January 23, 2026

Last Update Submit

February 2, 2026

Conditions

Keywords

Vitamin C supplementGlutathione supplement

Outcome Measures

Primary Outcomes (3)

  • The change of skin tone

    Chroma Meter MM500 was utilized to measure face skin tone. Units: Individual Typology Angle (ITA°)

    Change from Baseline skin tone at 12 weeks

  • The change of visible spots

    VISIA Complexion Analysis was utilized to measure visible spots on face. Units: the amount of detectable visible spots

    Change from Baseline visible spots at 12 weeks

  • The change of UV spots

    VISIA Complexion Analysis was utilized to measure UV spots on face. Units: the amount of detectable UV spots

    Change from Baseline UV spots at 12 weeks

Secondary Outcomes (12)

  • The change of skin hydration

    Change from Baseline skin hydration at 12 weeks

  • The change of skin redness

    Change from Baseline skin redness at 12 weeks

  • The change of skin melanin index

    Change from Baseline skin melanin index at 12 weeks

  • The change of skin elasticity

    Change from Baseline skin elasticity at 12 weeks

  • The change of brown spots

    Change from Baseline brown spots at 12 weeks

  • +7 more secondary outcomes

Other Outcomes (5)

  • The change of self-assessment skin condition

    Change from Baseline skin condition at 12 weeks

  • The change of self-assessment fatigue level

    Change from Baseline fatigue level at 12 weeks

  • The change of self-assessment Low Immunity level

    Change from Baseline Low Immunity level at 12 weeks

  • +2 more other outcomes

Study Arms (2)

Placebo sachet

PLACEBO COMPARATOR
Dietary Supplement: Placebo sachet

Vitamin C and Glutathione Liquid Sachet

EXPERIMENTAL
Dietary Supplement: Vitamin C and Glutathione Liquid Sachet

Interventions

consume 1 sachet of the test samples daily for 12 consecutive weeks

Also known as: Lipo GLUTA-C
Vitamin C and Glutathione Liquid Sachet
Placebo sachetDIETARY_SUPPLEMENT

consume 1 sachet of the test samples daily for 12 consecutive weeks

Placebo sachet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy male or female adults, aged 18-65 years old;
  • Commitment not to use products having activity comparable with that of the product to be tested during the study period;
  • Free of any dermatological or systemic disorder that would interfere with results.

You may not qualify if:

  • Subject with obvious skin surface damage;
  • Subject who had oral or topical medication which may affect skin condition within 1 month;
  • Individuals with known allergies to cosmetics, medications, or foods (especially those allergic to legumes/soy);
  • Pregnant or breastfeeding individuals;
  • Received facial laser therapy, chemical peeling in the past 2 months.
  • Individuals unwilling to allow publication or public disclosure of photographs taken as part of the study results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chia Nan University of Pharmacy & Science

Pingtung City, 928, Taiwan

RECRUITING

MeSH Terms

Conditions

Skin Diseases

Interventions

Ascorbic Acid

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • Chia-Hua Liang, Ph.D.

    Chia Nan University of Pharmacy & Science

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2026

First Posted

January 30, 2026

Study Start

January 24, 2026

Primary Completion (Estimated)

May 18, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

February 4, 2026

Record last verified: 2026-02

Locations